Kapake

Paracetamol and Codeine Phosphate Hemihydrate, the active ingredient in Kapake, is a combination analgesic presented as an oral formulation for systemic use. It provides relief of mild to moderate pain and reduces fever in adult patients when other non‑opioid options are insufficient.

GNH USA supplies Kapake as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, across multiple regions and regulatory environments, ensuring consistent quality and reliable delivery to meet the needs of diverse healthcare providers through robust supply chain management.

Kapake, a combination analgesic, is indicated for conditions where pain or fever requires stronger relief than paracetamol alone. - Mild to moderate pain: provides effective analgesia when non‑opioid analgesics are insufficient. - Post‑operative pain: helps control pain after surgical procedures. - Dental pain: relieves acute dental discomfort. - Fever: reduces elevated body temperature associated with infection or inflammation. - Musculoskeletal pain: eases discomfort from strains, sprains, or back pain.

Kapake may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: feeling of stomach upset. - Constipation: reduced bowel movements. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness. - Vomiting: expulsion of stomach contents. - Dry mouth: reduced salivary flow.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Hepatotoxicity: liver injury, especially with high paracetamol doses. - Dependence or abuse potential: risk of opioid misuse. - Seizures: convulsive episodes. - Hypotension: unusually low blood pressure.

When prescribing Kapake, consider the following precautions to ensure safe use. - Liver function assessment: evaluate hepatic health before initiating therapy. - Opioid tolerance evaluation: confirm patient is opioid‑naïve or tolerant. - Concomitant CNS depressants: avoid or limit use with alcohol, benzodiazepines, or antihistamines. - Renal impairment: adjust use in patients with reduced kidney function. - Risk of dependence: monitor for signs of misuse or addiction. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Kapake can interact with other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Other opioid analgesics: combined use may cause profound respiratory depression. - CNS depressants (e.g., benzodiazepines, alcohol): increase sedation and respiratory risk.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may reduce conversion of codeine to morphine, decreasing analgesic effect. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may lower plasma levels of both components. - NSAIDs: concurrent use can raise risk of gastrointestinal bleeding.